Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Kornélia Polyák, Charles Y. Lin et al.|Nature|2016Cited by 629
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic ResistanceKunihiko Hinohara, Kornélia Polyák, Ganesha Rai et al.|Cancer Cell|2018Cited by 255
JARID1B Is a Luminal Lineage-Driving Oncogene in Breast CancerKornélia Polyák, Zhenhua Wu, Hege G. Russnes et al.|Cancer Cell|2014Cited by 208
Role of COX-2 in epithelial–stromal cell interactions and progression of ductal carcinoma in situ of the breastMin Hu, Kornélia Polyák, Guillermo Peluffo et al.|Proceedings of the National Academy of Sciences|2009Cited by 202
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E. Stevens, Kornélia Polyák, Guillermo Peluffo et al.|Cancer Research|2022Cited by 101